United States· US:51672-2150_35328d05-d4b5-7aac-e063-6294a90a2f8b
Adapalene
A adapalene product containing adapalene, registered in United States by Sun Pharmaceutical Industries, Inc.. The same ATC class is registered in 16 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Adapalene is registered in 16 of 19 countries.
Countries holding a registration under ATC D10AD03 (adapalene), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Adapalene · ATC D10AD03
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ADAPALENE
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Country
- United States (US)
- ATC code
- D10AD03
- ATC class
- Adapalene
- Defined daily dose
- 1 mg, T
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1151672-2150-6
- ndc1151672215011 TUBE in 1 CARTON (51672-2150-1) / 15 g in 1 TUBE
- ndc1151672215061 TUBE in 1 CARTON (51672-2150-6) / 45 g in 1 TUBE
- ndc1151672-2150-1
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
80 interactions on record for adapalene.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Adapalene · interactions on record
80 records
- 1 severe
- 8 moderate
- 71 info
Most severe, free to view
- Aminolevulinic acidL01XD04severe
- Salicylic acidD01AE12moderate
- IsotretinoinD10AD04moderate
- Benzoyl peroxideD10AE01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Adapalene in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandAcnelecBausch Health Ireland Ltd.
- NetherlandsDifferin Gel 1 mg/g, gelEuro Registratie Collectief B.V.
- FinlandDifferinParanova Oy
- SpainDIFFERINE 1 mg/g GELLaboratorios Galderma S.A.
- SwedenDifferin 1 mg/g GelGalderma Nordic AB
- IcelandDifferinGalderma Nordic AB*
- United KingdomAdapalene 0.1% creamPhoenix Healthcare Distribution Ltd
- BelgiumAcnapalen 1 mg/g - 25 mg/gLaboratoires Bailleul
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Differin
- Belgium · Differin
- Cyprus · Adaferin
- Czechia · Belakne, Differine
- Germany · Differin, Dipalen
- Denmark · Redap
- Estonia · Differin
- Spain · Differine
- Finland · Differin
- France · Adapalene Teva, Adapalene Zentiva
- United Kingdom (Northern Ireland) · Differin
- Greece · Adaferin
- Croatia · Sona
- Hungary · Differin
- Ireland · Differin
- Iceland · Differin
- Italy · Differin
- Lithuania · Differin
- Luxembourg · Differin
- Latvia · Differin
- Malta · Differin
- Netherlands · Differin
- Norway · Differin
- Poland · Acnelec, Differin
- Portugal · Differin
- Sweden · Differin
- Slovenia · Belakne
- Slovakia · Belakne, Differine
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eb36bd2b-15a5-4962-b18e-3e2e75dbbea4 GET /v1/drugs/eb36bd2b-15a5-4962-b18e-3e2e75dbbea4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "1",
"substance": "ADAPALENE",
"productndc": "51672-2150",
"dosage_form": "GEL",
"dea_schedule": null,
"strength_unit": "mg/g",
"application_number": "ANDA215940",
"marketing_category": "ANDA"
}See everything about adapalene.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.